Skip to content

Clinical Study on the Course of Antibiotic Treatment for Elderly Community-Acquired Pneumonia

Clinical Study on the Course of Antibiotic Treatment for Elderly Community-Acquired Pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126782
Enrollment
Unknown
Registered
2026-06-15
Start date
2026-06-15
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-Acquired Pneumonia

Interventions

case series:None

Sponsors

Beijing Geriatric Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 65; 2.Meet the diagnostic criteria for community-acquired pneumonia; 3.After admission, the patient received antibacterial drug treatment. 4.Subjects of prospective studies can cooperate with follow-up visits and sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1.Severe CAP requiring ICU monitoring or mechanical ventilation; 2.Those with a clear or highly suspected diagnosis of tuberculosis, fungal infection, pulmonary abscess, necrotizing pneumonia, acute infection of bronchiectasis, or other conditions requiring an extended or special treatment course; 3.Severe immunosuppressive status, including organ transplantation, active hematological malignancies, recent chemotherapy, or long-term use of high-dose hormones/immunosuppressants, etc. 4.Those with a confirmed allergy to the main antibacterial drugs intended for the study, or those with severe hepatic and renal insufficiency who are unable to complete the scheduled treatment; 5.Patients who have received continuous systemic antibacterial therapy for more than 48 hours before hospital admission and for whom the treatment course cannot be accurately assessed.

Design outcomes

Primary

MeasureTime frame
Clinical cure rate;

Secondary

MeasureTime frame
30-day cure rate;30-day all-cause mortality;Incidence of antibacterial drug-related adverse events;

Countries

China

Contacts

Public ContactWu Hailing

Beijing Geriatric Hospital

helin-wu.123@163.com+86 10 83183581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026